Fecal Volatile Organic Compounds and Microbiota Associated with the Progression of Cognitive Impairment in Alzheimer's Disease.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Dec 2022
Historique:
received: 29 11 2022
revised: 22 12 2022
accepted: 27 12 2022
entrez: 8 1 2023
pubmed: 9 1 2023
medline: 11 1 2023
Statut: epublish

Résumé

Metabolites produced by an altered gut microbiota might mediate the effects in the brain. Among metabolites, the fecal volatile organic compounds (VOCs) are considered to be potential biomarkers. In this study, we examined both the VOCs and bacterial taxa in the feces from healthy subjects and Alzheimer's disease (AD) patients at early and middle stages. Remarkably, 29 fecal VOCs and 13 bacterial genera were differentiated from the healthy subjects and the AD patients. In general, higher amounts of acids and esters were found in in the feces of the AD patients and terpenes, sulfur compounds and aldehydes in the healthy subjects. At the early stage of AD, the most relevant VOCs with a higher abundance were short-chain fatty acids and their producing bacteria,

Identifiants

pubmed: 36614151
pii: ijms24010707
doi: 10.3390/ijms24010707
pmc: PMC9821163
pii:
doi:

Substances chimiques

Volatile Organic Compounds 0
Fatty Acids, Volatile 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerio de Ciencia e Innovación.
ID : 18.06.07.3005 PID2019-105632RB-I00

Références

Anal Chim Acta. 2019 Mar 7;1050:95-104
pubmed: 30661596
Foods. 2015 Nov 02;4(4):645-653
pubmed: 28231227
PLoS One. 2015 Jul 13;10(7):e0132227
pubmed: 26168044
Appl Microbiol Biotechnol. 2021 Aug;105(14-15):5785-5794
pubmed: 34312713
BMC Microbiol. 2021 Aug 12;21(1):226
pubmed: 34384375
mBio. 2019 May 7;10(3):
pubmed: 31064831
Diagnostics (Basel). 2021 Jun 15;11(6):
pubmed: 34203609
Gut Microbes. 2021 Jan-Dec;13(1):1-21
pubmed: 33525961
J Chromatogr A. 2020 Mar 15;1614:460717
pubmed: 31780078
Brain Behav Immun. 2019 Aug;80:633-643
pubmed: 31063846
Microbiome. 2018 Dec 13;6(1):221
pubmed: 30545401
EBioMedicine. 2019 Sep;47:529-542
pubmed: 31477562
Sci Rep. 2017 Oct 19;7(1):13537
pubmed: 29051531
PLoS One. 2022 Aug 24;17(8):e0273036
pubmed: 36001607
J Proteome Res. 2012 Dec 7;11(12):5573-85
pubmed: 23116228
Adv Immunol. 2014;121:91-119
pubmed: 24388214
J Alzheimers Dis. 2022;88(3):1103-1114
pubmed: 35754271
Nat Rev Immunol. 2016 May 27;16(6):341-52
pubmed: 27231050
mSystems. 2022 Feb 22;7(1):e0000422
pubmed: 35133187
Eur J Neurol. 2018 Jan;25(1):59-70
pubmed: 28872215
J Neural Transm (Vienna). 2015 Sep;122(9):1319-22
pubmed: 25680441
BMC Complement Altern Med. 2013 Oct 18;13:268
pubmed: 24134394
Aliment Pharmacol Ther. 1998 Jun;12(6):499-507
pubmed: 9678808
J Pers Med. 2022 Feb 28;12(3):
pubmed: 35330372
J Agric Food Chem. 2017 Jan 25;65(3):544-550
pubmed: 28048941
Mol Neurobiol. 2019 Mar;56(3):1841-1851
pubmed: 29936690
Science. 2012 Jun 8;336(6086):1262-7
pubmed: 22674330
Food Funct. 2021 Nov 1;12(21):10994-11008
pubmed: 34657937
Alzheimers Res Ther. 2022 Feb 14;14(1):35
pubmed: 35164860
J Alzheimers Dis. 2018;63(4):1337-1346
pubmed: 29758946
J Alzheimers Dis. 2011;26(1):187-97
pubmed: 21593570
Neurobiol Aging. 2017 Jan;49:60-68
pubmed: 27776263
J Neurogastroenterol Motil. 2019 Jan 31;25(1):48-60
pubmed: 30646475
Curr Alzheimer Res. 2019;16(10):963-973
pubmed: 31660828
Microbiome. 2018 Mar 21;6(1):55
pubmed: 29562936
Int J Mol Sci. 2020 Mar 18;21(6):
pubmed: 32197305
J Clin Psychiatry. 1996 May;57(5):190-8
pubmed: 8626349
Gut. 2022 Nov;71(11):2233-2252
pubmed: 35017199
Anal Chim Acta. 2019 Sep 6;1070:51-59
pubmed: 31103167
Aging (Albany NY). 2022 Jan 14;14(1):477-496
pubmed: 35027502
Molecules. 2015 Apr 22;20(4):7329-58
pubmed: 25911964
Aliment Pharmacol Ther. 2008 Jan 15;27(2):104-19
pubmed: 17973645
J Alzheimers Dis. 2020;78(2):683-697
pubmed: 33074224
Alzheimers Dement. 2019 Oct;15(10):1357-1366
pubmed: 31434623
Am J Psychiatry. 1982 Sep;139(9):1136-9
pubmed: 7114305
J Alzheimers Dis. 2017;60(4):1241-1257
pubmed: 29036812
Front Immunol. 2019 Mar 11;10:277
pubmed: 30915065
Cell. 2016 Jun 2;165(6):1332-1345
pubmed: 27259147
Oxid Med Cell Longev. 2021 Mar 10;2021:8887716
pubmed: 33777322
Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):419-34
pubmed: 27042902
Neurosci Biobehav Rev. 2022 Oct;141:104814
pubmed: 35934087
Biol Pharm Bull. 2020 Mar 1;43(3):409-417
pubmed: 31875578
Biomed Pharmacother. 2022 May;149:112898
pubmed: 35381448
Immun Inflamm Dis. 2019 Sep;7(3):229-236
pubmed: 31305026
Nutrition. 2022 Jan;93:111499
pubmed: 34735921
J Alzheimers Dis. 2018;66(4):1657-1682
pubmed: 30475761
J Biochem. 2011 Sep;150(3):257-66
pubmed: 21771869
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Nutrients. 2011 Oct;3(10):858-76
pubmed: 22254083
Nutrients. 2021 Jan 14;13(1):
pubmed: 33466861

Auteurs

Cristina Ubeda (C)

Departamento de Nutrición y Bromatología, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.

María D Vázquez-Carretero (MD)

Departamento de Fisiología, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.

Andrea Luque-Tirado (A)

Unidad de Memoria, Servicio de Neurología, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.

Rocío Ríos-Reina (R)

Departamento de Nutrición y Bromatología, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.

Ricardo Rubio-Sánchez (R)

Laboratorio de Análisis Clínicos, Hospital Universitario Valme, 41014 Sevilla, Spain.

Emilio Franco-Macías (E)

Unidad de Memoria, Servicio de Neurología, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.

Pablo García-Miranda (P)

Departamento de Fisiología, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.

María L Calonge (ML)

Departamento de Fisiología, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.

María J Peral (MJ)

Departamento de Fisiología, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH